Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ, Khachaturian ZS (2018) The cholinergic system in the pathophysiology and treatment of Alzheimers disease
Think of these junctions like the grout between tiles
"Some research looked at weight regain after people stop we wanted to know what happens to heart health when people stop." While GLP-1 drugs lead to weight loss, they also reduce cholesterol, blood pressure, inflammation and insulin resistance, the researcher noted
Still stuck
4(a) and (b))
These shifts may improve outcomes and justify larger trials testing durability beyond 32 weeks and generalizability, including effects on mortality benefits